BCI Marketplace
Depression Neuromodulation trials

Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder

RecruitingNCT07079826Phase: NAStarted 2026-05-27

Summary

This study is evaluating the Sparrow Link, a wearable device that delivers gentle electrical signals to nerves in the outer ear (a technique known as transcutaneous auricular neurostimulation, or tAN). The goal is to assess whether the device is feasible to use, acceptable to patients, and may help reduce opioid withdrawal symptoms in hospitalized adults being treated for opioid use disorder (OUD). Participants will be randomly assigned to receive either the active device or a sham (inactive) ve

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
None

Inclusion Criteria: Eligible participants must meet at least ONE of the following criteria: 1. Are continuing to experience opioid withdrawal symptoms: 1. Despite Maximal medical therapy with methadone, buprenorphine, full agonist opioids, or non-opioid medications, or 2. During tape

Locations

UPMC Presbyterian
Pittsburgh, Pennsylvania, United States

Interested in participating? View the full study details on ClinicalTrials.gov:

View on ClinicalTrials.gov →